Lexington, KENTUCKY2 Active Studies

Advanced Solid Tumors Clinical Trials in Lexington, KENTUCKY

Find 2 actively recruiting advanced solid tumors clinical trials in Lexington, KENTUCKY. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
810
Enrolling

Recruiting Advanced Solid Tumors Studies in Lexington

About Advanced Solid Tumors Clinical Trials in Lexington

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 2 advanced solid tumors clinical trials recruiting participants in Lexington, KENTUCKY. These studies are seeking a combined 810 participants. Research is being sponsored by National Cancer Institute (NCI), Astellas Pharma Global Development, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Lexington — FAQ

Are there advanced solid tumors clinical trials in Lexington?

Yes, there are 2 advanced solid tumors clinical trials currently recruiting in Lexington, KENTUCKY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lexington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lexington research site will contact you about next steps.

Are clinical trials in Lexington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lexington studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 2 active trials in Lexington are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov